RA
DRNA

Royce & Associates’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Royce & Associates’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,854
Closed -$47K – 1201
2020
Q2 		$47K Buy
+1,854
New +$47K ﹤0.01% 1042